Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 31 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Benralizumab for treating eosinophilic oesophagitis in people aged 12-65 years	Benralizumab (Fasenra; MEDI563)	Eosinophilic oesophagitis	Gastroenterology	2022	View \| Download
Budesonide for Ulcerative Proctitis	Budesonide gastro-resistant (Budenofalk)	Ulcerative proctitis	Gastroenterology	2021	View \| Download
Budesonide granules for induction of remission in lymphocytic colitis – first line	Budesonide gastro-resistant (Budenofalk)	Lymphocytic colitis	Gastroenterology , Immunology	2020	View \| Download
Budesonide suspension for treating eosinophilic oesophagitis in children and adolescents	Budesonide orodispersible (Jorveza)	Eosinophilic oesophagitis	Gastroenterology , Immunology	2023	View \| Download
Dupilumab for eosinophilic oesophagitis in paediatric patients	Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893)	Eosinophilic oesophagitis	Gastroenterology , Immunology	2023	View \| Download
Dupilumab for treating eosinophilic oesophagitis in people aged 12 years and older	Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893)	Eosinophilic oesophagitis	Gastroenterology , Immunology	2022	View \| Download
Eflornithine in combination with Sulindac for Familial Adenomatus Polyposis	Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) , Sulindac	Familial adenomatous polyposis (FAP)	Gastroenterology , Genetic Disorders	2018	View \| Download
Etrasimod for treating moderately to severely active ulcerative colitis	Etrasimod (ADP334)	Ulcerative colitis	Gastroenterology	2022	View \| Download
Etrolizumab for Crohn’s Disease	Etrolizumab (PRO145223; RG7413; rhuMAb Beta7)	Crohn's disease	Gastroenterology , Immunology	2021	View \| Download
Etrolizumab for treating moderately to severely active ulcerative colitis in adults	Etrolizumab (PRO145223; RG7413; rhuMAb Beta7)	Ulcerative colitis	Gastroenterology	2020	View \| Download